Models like BRCAPRO and BOADICEA are specifically tailored for individuals with a family history of breast and ovarian cancers, providing valuable insights into genetic mutations, including BRCA1 and BRCA2, as primary risk factors. This evidence concerns the gene BRCA1 and ovarian carcinoma.